SU1807595A1 - Agent for treatment against mercury intoxication - Google Patents
Agent for treatment against mercury intoxicationInfo
- Publication number
- SU1807595A1 SU1807595A1 SU4749558/14A SU4749558A SU1807595A1 SU 1807595 A1 SU1807595 A1 SU 1807595A1 SU 4749558/14 A SU4749558/14 A SU 4749558/14A SU 4749558 A SU4749558 A SU 4749558A SU 1807595 A1 SU1807595 A1 SU 1807595A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- agent
- treatment against
- against mercury
- mercury intoxication
- intoxication
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
FIELD: medicine, pharmacology, therapy. SUBSTANCE: proposed agent is lespeflan that is administrated by oral route (1-3 spoons, 2-4 times per a day). Proposed agent is used for organism detoxication in patient poisoned with mercury. EFFECT: enhanced effectiveness of agent. 5 tbl
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU4749558/14A SU1807595A1 (en) | 1989-10-16 | 1989-10-16 | Agent for treatment against mercury intoxication |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU4749558/14A SU1807595A1 (en) | 1989-10-16 | 1989-10-16 | Agent for treatment against mercury intoxication |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1807595A1 true SU1807595A1 (en) | 1996-08-10 |
Family
ID=60536933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU4749558/14A SU1807595A1 (en) | 1989-10-16 | 1989-10-16 | Agent for treatment against mercury intoxication |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1807595A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2670070C2 (en) * | 2013-05-10 | 2018-10-17 | Эридел С.П.А. | Process for preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes |
-
1989
- 1989-10-16 SU SU4749558/14A patent/SU1807595A1/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2670070C2 (en) * | 2013-05-10 | 2018-10-17 | Эридел С.П.А. | Process for preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9504415A (en) | Aspartate protease substrate isoesters antiviral ethers. | |
DE3374300D1 (en) | Stabilized activated oxygen and medicaments containing this stabilized activated oxygen | |
TW250435B (en) | ||
ATE67677T1 (en) | MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE. | |
IL113651A0 (en) | Pharmaceutical compositions containing alendronate and their use | |
EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
HK1003980A1 (en) | Dosage form for dispensing drug and human therapy | |
NO923859L (en) | DRUG | |
ES2000743A6 (en) | Pharmaceutical dosage unit. | |
HU883863D0 (en) | Process for the preparation of producing and/or portionly form of therapeutical agents | |
JPS6438020A (en) | Therapy | |
DK0668077T3 (en) | Products containing G-CSF and TNF-binding protein | |
ATE183923T1 (en) | ENTERAL PREPARATIONS FOR CANCER THERAPY | |
HU907959D0 (en) | Medical preparations | |
GR3033253T3 (en) | Tri(platinum) complexes | |
DE69004532D1 (en) | Medicinal preparations containing topical defibrotide. | |
ES8707488A1 (en) | Biologically active ketone derivative, preparation and use. | |
ZA877901B (en) | Active compounds for use in the treatment of tumors | |
IE45054L (en) | Veterinary composition | |
SU1807595A1 (en) | Agent for treatment against mercury intoxication | |
ATE86112T1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATED NOSE MUCOUS. | |
ES2012547A6 (en) | Use of metalloporphyrins to reverse the toxic effect of tumor therapy. | |
TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
MY111746A (en) | Therapeutic nucleosides. | |
ES8704903A1 (en) | 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine-N-oxide and medical compositions using it. |